| http://dbpedia.org/ontology/abstract
|
Rovalpituzumab tesirine (Rova-T) is an exp … Rovalpituzumab tesirine (Rova-T) is an experimental antibody-drug conjugate targeting the protein DLL3 on tumor cells. It was originally developed by and was purchased by AbbVie. It was tested for use in small-cell lung cancer, but development was terminated after unsuccessful phase III trial.inated after unsuccessful phase III trial.
|
| http://dbpedia.org/ontology/casNumber
|
1613313-09-9
|
| http://dbpedia.org/ontology/chemicalFormula
|
C6416H9894N1698O2028S46 (non-glycosylated)
|
| http://dbpedia.org/ontology/fdaUniiCode
|
P256HB60FF
|
| http://dbpedia.org/ontology/kegg
|
D10981
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Tesirine_skeletal.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageID
|
53047506
|
| http://dbpedia.org/ontology/wikiPageLength
|
5648
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1096055629
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Pyrrolobenzodiazepine +
, http://dbpedia.org/resource/Valine +
, http://dbpedia.org/resource/Maleimide +
, http://dbpedia.org/resource/AbbVie +
, http://dbpedia.org/resource/Phases_of_clinical_research +
, http://dbpedia.org/resource/Category:Orphan_drugs +
, http://dbpedia.org/resource/Dimer_%28chemistry%29 +
, http://dbpedia.org/resource/Peptide +
, http://dbpedia.org/resource/Small-cell_lung_cancer +
, http://dbpedia.org/resource/Category:Experimental_cancer_drugs +
, http://dbpedia.org/resource/File:Tesirine_skeletal.svg +
, http://dbpedia.org/resource/Stemcentrx +
, http://dbpedia.org/resource/Polyethylene_glycol +
, http://dbpedia.org/resource/Cysteine +
, http://dbpedia.org/resource/Antibody-drug_conjugate +
, http://dbpedia.org/resource/Glycosylated +
, http://dbpedia.org/resource/Category:Monoclonal_antibodies_for_tumors +
, http://dbpedia.org/resource/Alanine +
, http://dbpedia.org/resource/Category:Antibody-drug_conjugates +
, http://dbpedia.org/resource/Vadastuximab_talirine +
, http://dbpedia.org/resource/DLL3 +
|
| http://dbpedia.org/property/atcPrefix
|
None
|
| http://dbpedia.org/property/casNumber
|
1613313
|
| http://dbpedia.org/property/chemicalFormula
|
C6416H9894N1698O2028S46
|
| http://dbpedia.org/property/chemspiderid
|
none
|
| http://dbpedia.org/property/kegg
|
D10981
|
| http://dbpedia.org/property/mabType
|
mab
|
| http://dbpedia.org/property/source
|
zu
|
| http://dbpedia.org/property/target
|
http://dbpedia.org/resource/DLL3 +
|
| http://dbpedia.org/property/type
|
mab
|
| http://dbpedia.org/property/unii
|
P256HB60FF
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Monoclonals_for_tumors +
, http://dbpedia.org/resource/Template:Clear +
, http://dbpedia.org/resource/Template:Infobox_drug +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Orphan_drugs +
, http://dbpedia.org/resource/Category:Experimental_cancer_drugs +
, http://dbpedia.org/resource/Category:Monoclonal_antibodies_for_tumors +
, http://dbpedia.org/resource/Category:Antibody-drug_conjugates +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Rovalpituzumab_tesirine?oldid=1096055629&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Tesirine_skeletal.svg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Rovalpituzumab_tesirine +
|
| owl:sameAs |
https://global.dbpedia.org/id/2ofA4 +
, http://dbpedia.org/resource/Rovalpituzumab_tesirine +
, http://www.wikidata.org/entity/Q30314129 +
, http://yago-knowledge.org/resource/Rovalpituzumab_tesirine +
|
| rdf:type |
http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/ontology/MonoclonalAntibody +
, http://dbpedia.org/ontology/Drug +
|
| rdfs:comment |
Rovalpituzumab tesirine (Rova-T) is an exp … Rovalpituzumab tesirine (Rova-T) is an experimental antibody-drug conjugate targeting the protein DLL3 on tumor cells. It was originally developed by and was purchased by AbbVie. It was tested for use in small-cell lung cancer, but development was terminated after unsuccessful phase III trial.inated after unsuccessful phase III trial.
|
| rdfs:label |
Rovalpituzumab tesirine
|
